TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18086727

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 16152823

Group type: EXPERIMENTAL
Intervention: Fuzheng Jiangnian Capsule (FZJN)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Compound Salviae droplet pill (CSDP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aspirin (ASP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 90
Study: 13678873

Group type: EXPERIMENTAL
Intervention: Ximelagatran (combined groups)
Number of subjects: 1883

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1883
Study: 11770234

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) for at least 4 hours per day in not more than 3 sittings
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (standard care: incubator or open care system)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 28
Study: 8993243

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (2 x 10(6) KIU or 280 mg in the pump)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 36
Study: 7952372

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 50
Study: 2962617

Group type: EXPERIMENTAL
Intervention: Ioxaglate (Hexabrix)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Iohexol (Omnipaque)
Number of subjects: 107
Study: 2199732

Group type: EXPERIMENTAL
Intervention: Glucagon (2 micrograms kg‐1 hr‐1)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Insulin (0.125 U kg‐1 hr‐1)
Number of subjects: 5

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 5
Study: 5090825

Group type: EXPERIMENTAL
Intervention: Passive exercise of the lower limb during surgery (using a motorized foot mover, pedalling one leg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (unpedalled leg)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Passive exercise of the lower limb during surgery
Number of subjects: 47
Study: 31142943

Group type: EXPERIMENTAL
Intervention: 1% Vitamin K cream
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 1% phenytoin cream
Number of subjects: 63

Group type: COMPARATOR
Intervention: Eucerin
Number of subjects: 63
Study: 28427763

Group type: EXPERIMENTAL
Intervention: Telerehabilitation program delivered via online video-conferencing for 12 weeks
Number of subjects: 17
Study: 25836986

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) from healthy donors
Number of subjects: 50

Group type: COMPARATOR
Intervention: Autologous fecal microbiota (control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: FMT group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 23725684

Group type: EXPERIMENTAL
Intervention: Propofol (group P, n = 23)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sevoflurane (group S, n = 21)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 44
Study: 22776976

Group type: EXPERIMENTAL
Intervention: Pediatric LDH group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Adult LDH group
Number of subjects: 32
Study: 19182362

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17192957

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 102
Study: 15765858

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided puncture of the femoral artery
Number of subjects: 112

Group type: COMPARATOR
Intervention: Traditional palpation-guided vessel cannulation
Number of subjects: 112
Study: 11170981

Group type: EXPERIMENTAL
Intervention: CP Vac-Env-Pro
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (CP rabies or gp120 vaccine only)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: rgp120
Number of subjects: 59
Study: 9756781

Group type: EXPERIMENTAL
Intervention: Pleconaril oral solution (200 mg) coadministered with a standard English breakfast
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pleconaril oral solution (200 mg) in fasting state
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pleconaril oral solution (200 mg)
Number of subjects: 12
Study: 7876406

Group type: EXPERIMENTAL
Intervention: CI-977 (5 micrograms)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CI-977 (15 micrograms)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CI-977 (25 micrograms)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 3278595

Group type: EXPERIMENTAL
Intervention: Heat probe thermocoagulation
Number of subjects: 78

Group type: COMPARATOR
Intervention: Pure alcohol injection
Number of subjects: 78
Study: 31049139

Group type: EXPERIMENTAL
Intervention: Cordyceps militaris (COG, 100 mg daily)
Number of subjects: 0
Study: 28434116

Group type: EXPERIMENTAL
Intervention: IDO activity
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: TPH activity
Number of subjects: 149
Study: 25350981

Group type: EXPERIMENTAL
Intervention: Droxidopa (100-600 mg, 3× daily)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Droxidopa
Number of subjects: 101

Group type: COMPARATOR
Intervention: Droxidopa and Placebo
Number of subjects: 101
Study: 23404689

Group type: EXPERIMENTAL
Intervention: Cell salvage of cardiotomy suction blood
Number of subjects: 25

Group type: COMPARATOR
Intervention: No cell salvage
Number of subjects: 25
Study: 21602542

Group type: EXPERIMENTAL
Intervention: Fluctuations in twice‐daily peak expiratory flow (PEF) over 6 months
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Mean percentage predicted PEF (%predPEF)
Number of subjects: 291
Study: 18581891

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of salmon calcitonin (50 U) three times a week for 18 months
Number of subjects: 108

Group type: COMPARATOR
Intervention: Oral administration of calcium carbonate 1500 mg tid and rocaltrol 0.25 microg qn for 18 months (Control)
Number of subjects: 108
Study: 16344320

Group type: EXPERIMENTAL
Intervention: FDR gemcitabine 1,000 mg/m2 at 10 mg/m2/min with cisplatin 20 mg/m2 on days 1 and 8 of a 21-day cycle
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: FDR gemcitabine with cisplatin
Number of subjects: 51
Study: 12975186

Group type: EXPERIMENTAL
Intervention: Cold gel (Ice Power)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 74
Study: 10800798

Group type: EXPERIMENTAL
Intervention: heparin-coated circuit with aprotinin (HCO-A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: heparin-coated circuit without aprotinin (HCO)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: uncoated circuit with aprotinin (C-A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: uncoated circuit without aprotinin (C)
Number of subjects: 200
Study: 8738684

Group type: EXPERIMENTAL
Intervention: Propofol and alfentanil anesthesia (PA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Thiopental and nitrous oxide anesthesia (TN)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison of sick-leave between PA and TN groups
Number of subjects: 39

Group type: COMPARATOR
Intervention: Economic impact of sick-leave
Number of subjects: 39
Study: 1640004

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg administered twice on day 8
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo administered twice on day 8
Number of subjects: 20
Study: 6090529

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 50
Study: 31227317

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia with propofol
Number of subjects: 183

Group type: COMPARATOR
Intervention: Desflurane anesthesia
Number of subjects: 183
Study: 29699403

Group type: EXPERIMENTAL
Intervention: Gluten consumption between 11 and 36 months
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: HLA genotype
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 225

Group type: COMPARATOR
Intervention: Gluten consumption among three centers
Number of subjects: 225

Group type: COMPARATOR
Intervention: Celiac vs non-celiac children
Number of subjects: 225
Study: 27270645

Group type: EXPERIMENTAL
Intervention: Embedded cognitive rehabilitation intervention (n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Supportive client-centered therapy (control, n = 8)
Number of subjects: 18
Study: 24962744

Group type: EXPERIMENTAL
Intervention: BMT+TAG
Number of subjects: 61

Group type: COMPARATOR
Intervention: BMT
Number of subjects: 61
Study: 22389945

Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance (CO‐OP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard Occupational Therapy (SOT)
Number of subjects: 8
Study: 20407057

Group type: EXPERIMENTAL
Intervention: Early tracheotomy (n = 209; 145 received tracheotomy)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Late tracheotomy (n = 210; 119 received tracheotomy)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Early tracheotomy
Number of subjects: 600
Study: 18672641

Group type: EXPERIMENTAL
Intervention: Quinaril (20 mg quinapril hydrochloride)
Number of subjects: 24
Study: 16091254

Group type: EXPERIMENTAL
Intervention: Immune-based therapies as an adjunct to antiretroviral treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immune-based therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunomodulating therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods targeting the latent memory T-cell reservoir of virus
Number of subjects: 0
Study: 12093332

Group type: EXPERIMENTAL
Intervention: Bovine pericardium (BP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Dacron
Number of subjects: 92
Study: 10575530

Group type: EXPERIMENTAL
Intervention: Reteplase (administered in bolus injections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus TNK-t-PA
Number of subjects: 0
Study: 7677218

Group type: EXPERIMENTAL
Intervention: Paromomycin ointment applied twice a day from day 1 through day 14
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Paromomycin ointment
Number of subjects: 115

Group type: COMPARATOR
Intervention: Paromomycin ointment and Placebo
Number of subjects: 115
Study: 2148282

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 20
Study: 382379

Group type: COMPARATOR
Intervention: Antibiotics + Placebo
Number of subjects: 378

Group type: COMPARATOR
Intervention: Antibiotics + Pseudoephedrine
Number of subjects: 378

Group type: COMPARATOR
Intervention: Antibiotics + Triprolidine
Number of subjects: 378

Group type: COMPARATOR
Intervention: Antibiotics + Combination of agents
Number of subjects: 378
Study: 31821157

Group type: EXPERIMENTAL
Intervention: β-hydroxybutyrate infusion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (saline) infusion
Number of subjects: 18
Study: 30420448

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg + High-Dose Interferon-α2b (HDI)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg + High-Dose Interferon-α2b (HDI)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ipilimumab alone
Number of subjects: 81
Study: 28985039

Group type: EXPERIMENTAL
Intervention: Moderate-fat diet high in monounsaturated fatty acids (MUFA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber diet (Nordic Nutrition Recommendations [NNR])
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Average Danish Diet (ADD)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Comparison of NNR to ADD
Number of subjects: 3

Group type: COMPARATOR
Intervention: Comparison of NNR to MUFA
Number of subjects: 3
Study: 26232942

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of cardiosphere-derived cells (CDCs)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 14
Study: 23478743

Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg daily, increased to 300 mg as tolerated)
Number of subjects: 1615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1615

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 1615
Study: 21099417

Group type: EXPERIMENTAL
Intervention: T-Clair SPHP700-3
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18355658

Group type: EXPERIMENTAL
Intervention: Baseline LOOH levels in the highest quartile
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Amlodipine treatment
Number of subjects: 634
Study: 16736344

Group type: EXPERIMENTAL
Intervention: Aprotinin (1 x 10(6) KIU loading dose before surgery and 5 x 10(5) KIU/h during surgery, gross dose: 2.5 x 10(6) KIU, n=36)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Saline solution (control, n=40)
Number of subjects: 76
Study: 14508028

Group type: EXPERIMENTAL
Intervention: Regular sleep after vaccination
Number of subjects: 19

Group type: COMPARATOR
Intervention: Staying awake after vaccination
Number of subjects: 19
Study: 11057006

Group type: EXPERIMENTAL
Intervention: Translated two‐object contours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symmetrical contours at different axis orientations
Number of subjects: 0
Study: 1360793

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (n = 11)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate (n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both treatments (Sodium nitroprusside and Fenoldopam)
Number of subjects: 21
Study: 2418716

Group type: EXPERIMENTAL
Intervention: Atracurium 1.2 mg . kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg . kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium 0.6 mg . kg‐1
Number of subjects: 30
Study: 31366601

Group type: EXPERIMENTAL
Intervention: mogamulizumab‐kpkc
Number of subjects: 372

Group type: COMPARATOR
Intervention: vorinostat
Number of subjects: 372
Study: 29716555

Group type: EXPERIMENTAL
Intervention: Robotic radical hysterectomy (RRH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Laparoscopic radical hysterectomy (LRH)
Number of subjects: 60
Study: 27138794

Group type: EXPERIMENTAL
Intervention: Raloxifene (120 mg per day orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24161158

Group type: EXPERIMENTAL
Intervention: MMF/prednisone
Number of subjects: 84

Group type: COMPARATOR
Intervention: CYC/prednisone
Number of subjects: 84
Study: 22041458

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 1439
Study: 19743503

Group type: EXPERIMENTAL
Intervention: Subcutaneous atacicept (single dose: 0.3, 1, 3, or 9 mg/kg; four weekly doses: 1 or 3 mg/kg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intravenous atacicept (single dose: 3, 9, or 18 mg/kg; multiple dose: 2 x 9 mg/kg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (3:1 ratio for Study 1; 5:1 ratio for Study 2)
Number of subjects: 96
Study: 19031818

Group type: EXPERIMENTAL
Intervention: Palatoplasty at age ≤ 3.0 years (Group A)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Palatoplasty at age > 6.0 years (Group C)
Number of subjects: 103
Study: 16261757

Group type: EXPERIMENTAL
Intervention: Modified Politzer device used in home setting over a 7-week period
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 94
Study: 11849464

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (10 mm Hg below baseline DBP)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Moderate blood pressure control (80 to 89 mm Hg)
Number of subjects: 480
Study: 10190639

Group type: EXPERIMENTAL
Intervention: Community intervention including community education, merchant education, and voluntary policy change.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison communities (no intervention).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intervention communities for younger students (7th graders).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intervention communities for older students (9th and 11th graders).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intervention communities for females.
Number of subjects: 100
Study: 8916626

Group type: COMPARATOR
Intervention: therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 2071252

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6337605

Group type: EXPERIMENTAL
Intervention: Dazoxiben (thromboxane synthetase inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30632915

Group type: EXPERIMENTAL
Intervention: In-depth interviews, photovoice, and participant observation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Emotional and economic support from families
Number of subjects: 15
Study: 27881556

Group type: EXPERIMENTAL
Intervention: Hypoxia (10% O2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise in hypoxia (10% O2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxia (21% O2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Exercise in normoxia (21% O2)
Number of subjects: 10
Study: 26596405

Group type: EXPERIMENTAL
Intervention: Web-based tailored asthma intervention
Number of subjects: 499

Group type: COMPARATOR
Intervention: Emergency department recruitment strategy
Number of subjects: 499

Group type: COMPARATOR
Intervention: Mail or telephone recruitment strategy
Number of subjects: 499

Group type: COMPARATOR
Intervention: Emergency department awareness activities
Number of subjects: 499
Study: 24589198

Group type: EXPERIMENTAL
Intervention: Specific problem-solving training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basic cognition training
Number of subjects: 0
Study: 22183156

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block with 20 ml of levobupivacaine 2.5 mg/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 20801975

Group type: EXPERIMENTAL
Intervention: Intervention group (shared decision making tool - ARRIBA‐Herz)
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1132
Study: 17940609

Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (5, 20, and 80 microg doses)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (80 microg dose)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (third dose at one year)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control vaccine (Hepatitis B vaccine - Recombivax)
Number of subjects: 54
Study: 15494430

Group type: EXPERIMENTAL
Intervention: R‐CVP (CVP plus rituximab)
Number of subjects: 321

Group type: COMPARATOR
Intervention: CVP (control)
Number of subjects: 321
Study: 12076551

Group type: EXPERIMENTAL
Intervention: Intervention group (increased fruit and vegetable consumption)
Number of subjects: 690
Study: 10211630

Group type: EXPERIMENTAL
Intervention: Breast cancer patients
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Breast cancer patients with stage III
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (n = 35)
Number of subjects: 35
Study: 7840291

Group type: COMPARATOR
Intervention: Athletes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hypertensives
Number of subjects: 25
Study: 1849532

Group type: EXPERIMENTAL
Intervention: Informed group (received letter about elevated blood pressure)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Informed group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (received neutral letter)
Number of subjects: 36
Study: 7314869

Group type: EXPERIMENTAL
Intervention: Sympathectomy
Number of subjects: 183

Group type: COMPARATOR
Intervention: No operation (Control)
Number of subjects: 183
Study: 31911146

Group type: EXPERIMENTAL
Intervention: Single-dose inactivated influenza vaccine (15 μg of each of the three seasonal influenza strains)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Double-dose inactivated influenza vaccine (15 μg of each of the three seasonal influenza strains)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Two single doses of inactivated influenza vaccine (15 μg of each of the three seasonal influenza strains, 1 month apart)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Double-dose inactivated influenza vaccine
Number of subjects: 800
Study: 31615643

Group type: EXPERIMENTAL
Intervention: Forward walking at preferred walking speed (PWS) for 3 minutes (pre) followed by 5 minutes walking at 80%, 100%, and 120% of PWS (forward walking)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Backward walking at 80%, 100%, and 120% of PWS
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Backward walking
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Forward and backward walking
Number of subjects: 22
Study: 28239833

Group type: EXPERIMENTAL
Intervention: Closure of mesenteric defect
Number of subjects: 2507

Group type: EXPERIMENTAL
Intervention: Non-closure of mesenteric defect
Number of subjects: 2507
Study: 26269098

Group type: EXPERIMENTAL
Intervention: AVATAR therapy (7 sessions)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Supportive counselling (SC)
Number of subjects: 142
Study: 23292667

Group type: EXPERIMENTAL
Intervention: Individualized exercise interventions during inpatient stays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0